Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_78d9f0fbe0564683897b98e2a20d745e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-047 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M11-041 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-553 |
filingDate |
2018-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b73096d3d559cdcb57cf6af650ff22e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cf5dc6c0d05637f3759c1e8c6db1a49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b89ad4887c155ed30c56be89f584f7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_678428d893b018034846c3780d6be9ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89d5f8d886410ad777f67ecfe808e3c6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12400fa2ee47d55e28383cbb2130769e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d6daf3d52d37b6661c7943bb9fd21a1 |
publicationDate |
2018-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018296568-A1 |
titleOfInvention |
Substrates for Drug Delivery Device and Methods of Preparing and Use |
abstract |
An assembly and method for producing a condensation aerosol are disclosed. The assembly includes a heat-conductive metal substrate with an oxidation resistant exterior surface and a drug composition film on the exterior surface and is for use in an aerosol device. The thickness of the film and the surface of the substrate is such that the aerosol formed by vaporizing and condensing the drug composition the aerosol contain 10% by weight or less drug-degradation products and at least 50% of the total amount of the drug composition in the film. The methods for treating the exterior surface include heat and chemical treatment and formation of a protective overcoat. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11241383-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022221530-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11717479-B2 |
priorityDate |
2003-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |